Pfizer to Use Genomatix Software and Databases

Pfizer is wasting no time to get the calculations running and numbers rolling. To stay in the market, they are attempting to find out as much as they can about potential side effects and other perhaps adverse affects of their drugs. Better than they find up them front, as it will make for better documented clinical trials even before they start. One more step towards the direction of personalized medicine. BD

NEW YORK (GenomeWeb News) – Genomatix Software said today that Pfizer has licensed use of its software and databases for use by Pfizer Pharmaceuticals’ sites around the world.

The Munich, Germany-based bioinformatics company said that Pfizer will use the software and data content “to help understand the molecular basis of how their potential drug targets may be co-regulated with other important targets, producing potential desirable or unwanted side effects.